Durect Corp (DRRX)

$0.88 0.04 (4.75%)

16:00 EDT DRRX Stock Quote Delayed 30 Minutes

DRRX Stock Earnings: Durect Beats EPS, Beats Revenue for Q4 2023

By InvestorPlace Earnings Mar 27, 2024

DRRX stock results show that Durect beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Why Is Durect (DRRX) Stock Down 64% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

3 Promising Biotech Stocks That Will Make Early Investors Rich

More Articles

Volume:

Previous Close -

Market Cap 21.64M

PE Ratio -1.70

EPS -0.52

Volume (Avg. Vol.) 138,740

Day's Range $0.82 - $0.91

52-Week Range $0.47 - $7.46

Dividend & Yield N/A (N/A)

DRRX Stock Predictions, Articles, and Durect Corp News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jul 24, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

7 Biotech Stocks Sitting in the Sweet Spot

By Louis Navellier and the InvestorPlace Research Staff Mar 24, 2023

Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable.

7 Stocks Under $10 to Buy in February

By Louis Navellier and the InvestorPlace Research Staff Feb 17, 2023

A stock under $10 to buy is more likely to be a growth stock with a longer runway to providing investors with some great returns.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Feb 6, 2023

We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday!

6 Penny Stocks With 1,000% Upside Potential

By Alex Sirois, InvestorPlace Contributor Jul 24, 2022

Each of these penny stocks with 1,000% upside potential could rise 10X in the future for investors with a high risk tolerance.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jun 9, 2022

Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thurday!

7 Penny Stocks to Buy Right Now As Trends Catalyze Opportunity

By Alex Sirois, InvestorPlace Contributor Aug 20, 2020

As we head further into August, a handful of penny stocks look like good opportunities. That said, here's seven penny stocks to buy.

5 Stocks Under $5 With Colossal Growth Prospects

By Maya Sasson, Writer, TipRanks Jan 31, 2020

While some argue you get what you pay for, others say that stocks trading at low levels can represent compelling opportunities.

HC Wainwright downgrades DURECT to neutral, removes price target (NASDAQ:DRRX)

From Seeking Alpha Nov 8, 2023

HC Wainwright downgrades DURECT (DRRX) after a Phase 2b study failure of its drug larsucosterol in the treatment of severe alcohol-associated hepatitis. Read more here.

Durect stock drops as lead drug fails in mid-stage trial

From Seeking Alpha Nov 8, 2023

Durect Corporation (DRRX) lost 63% on Wednesday as a mid-stage study for its lead drug larsucosterol fails in alcohol-associated hepatitis patients. Read more here.

Northland sees DURECT's upcoming data as

From Seeking Alpha Sep 14, 2023

Northland Capital Markets said it expects upcoming mid-stage data for DURECT’s (DRRX) drug larsucosterol to serve as a “major” near-term catalyst for the stock. Read more here.

Gail Maderis appointed chair of DURECT (NASDAQ:DRRX)

From Seeking Alpha Mar 21, 2023

DURECT (DRRX) on Tuesday announced that Gail Maderis has assumed the role of chair of the Board, effective March 17, 2023.

Analysts’ Top Healthcare Picks: Durect (DRRX), Denali Therapeutics (DNLI)

From TipRanks Dec 6, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Durect (DRRX – Research Report), Denali Therapeutics...

H.C. Wainwright Keeps Their Buy Rating on Durect (DRRX)

From TipRanks Sep 27, 2022

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Durect (DRRX – Research Report), with a price target of $6.00. The company...

ADVERTISEMENT